Videos and News

Sativa Wellness Group revenues soar, achieving their goal of opening 30 Covid-19 testing stores

26th May, 2021

Sativa Wellness Group Inc’s (LON:SWEL) (CSE: SWEI) Geremy Thomas talks to Proactive London’s Katie Pilbeam about their Q1 2021 financial statements.

PhytoVista Laboratories receive accreditation for testing of cannabinoids
(Proactive)

23rd April, 2021

Sativa Wellness Group Inc’s (LON:SWEL) Geremy Thomas talks to Proactive London’s Katie Pilbeam about subsidiary PhytoVista Laboratories , which has been was granted ISO/IEC 17025:2017 accreditation from the UK for the testing of cannabinoids.

Sativa Wellness Group Extends its reach in COVID testing (DirectorsTalk)

7th April 2021

Sativa Wellness Group Inc. (LON:SWEL) Executive Chairman Geremy Thomas joins DirectorsTalk to discuss now being listed on the UK government website to offer 2 and 8 day quarantine tests. Geremy explains where they are with the clinic roll-out and how this will impact revenues.

Sativa Wellness Looking To Deliver Covid-19 Jabs From 30 UK Locations
by BusinessCann

15th March, 2021

SATIVA Wellness’ pivot to Covid-19 testing work has exceeded expectations with plans afoot to open up a dozen new locations delivering blood tests, vaccines and vaccine boosters.
Previously know as The Sativa Group the name change to Sativa Wellness in October last year reflected its efforts in the fight against the pandemic.
read more…

Sativa Wellness Group expect a significant ramp up (Interview)

11th March, 2021

Sativa Wellness Group Inc. (AQSE:SWEL / CNSX:SWEL) Executive Chairman Germey Thomas joins DirectorsTalk Interviews to discuss reaching its £1m milestone for COVID testing. Geremy talks us through the milestone, the addition of further testing clinics including two mobile units, the significance of having 30 clinics to the company and how long Geremy thinks the PCR testing revenue stream will last.

Sativa Wellness Group on target to achieve 30 Covid-19 clinics by end of April after £1m milestone

10th March, 2021

Sativa Wellness Group Inc’s (LON:SWEL) Geremy Thomas talks to Proactive London’s Katie Pilbeam about its coronavirus (COVID-19) testing business which has now achieved over £1.1mln worth of bookings in less than four months since opening its first clinic in Bath, UK.

The company now has 17 operational clinics throughout the UK testing for COVID-19, in line with its target to have 30 clinics by the end of April.

Sativa seed to shelf CBD journey that the market can rely on

2nd March, 2021

Sativa Wellness Group Inc. (AQSE:SWEL / CNSX:SWEL) Executive Chairman Geremy Thomas joins DirectorsTalk to discuss its operations meeting the requirements of Good Manufacturing Practice and Good Hygiene Practice standards for food manufacturing. Geremy explains what this means for the company, the impact this has on the Novel Foods accreditation and now with David Beckham as a competitor, how he feels about that.

Sativa to focus on opportunities that will bring in profit and add value to company

22nd February 2021

Sativa Wellness Group Inc’s (LON:SWEL) Geremy Thomas talks to Proactive London about being back at the helm with his focus on generating cash and profit as well as reducing costs.

He says, ‘since I’ve been in place we’ve seen a doubling of our share price and I think that will continue to rise‘.

Play Video

FSA regulation key to industry and to the company

February 19, 2021

Sativa Wellness Group Inc. (CNSX:SWEL) Executive Chairman Geremy Thomas joins DirectorsTalk Interviews to discuss its novel food application to the FSA. Geremy explains why he has re-joined the board, the significance of the application announcement and the recent success of new listings in this CBD sector.

Sativa delighted with Cenkos appointment as it opens CBD wellness centre

July 3, 2019

Sativa Group PLC‘s (LON:SATI) Geremy Thomas caught up with Proactive London’s Andrew Scott following the opening of their first cannabidiol (CBD) wellness retail outlet in Bath at the weekend.

The Goodbody Wellness store was launched on Friday evening by Crispin Blunt, MP for Reigate and co-chair of the All Party Parliamentary Group for Drug Policy Reform.

Sativa Investments 'at the forefront' of developing UK medical cannabis market

Janurary 10, 2019

Geremy Thomas, founder and chief executive of Sativa Investments PLC (LON:SATI), caught up with Proactive London’s Andrew Scott to discuss the NEX-based medical cannabis investor’s trading and strategic update.

Sativa’s this week unveiled plans to become a first-mover seed-to-consumer business in the UK.

Sativa Investments PLC acquires UK-based PhytoVista Laboratories

July 3, 2018

Geremy Thomas, chief executive of Sativa Investments PLC (NEX:SATI), tells Proactive’s Andrew Scott they’ve agreed to buy PhytoVista Laboratories, a UK-based lab that tests cannabis oils and hemp products, for £435,000.

Sativa Investments has "unique" market position for UK cannabis investors

May 23, 2018

Sativa Investments PLC’s Geremy Thomas tells Proactive that the medicinal cannabis market has seen explosive growth all over the world, particularly in Vancouver, Canada.

He adds that Sativa has a unique position in the UK market that allows UK investors to benefit from companies in regulated markets.